Preventing Osteoporosis in Patients with Spinal Cord Injury (SCI)
- Conditions
- OsteoporosisSpinal Cord Injury (SCI)Musculoskeletal - OsteoporosisNeurological - Other neurological disordersInjuries and Accidents - FracturesInjuries and Accidents - Other injuries and accidents
- Registration Number
- ACTRN12618000915257
- Lead Sponsor
- orthern Sydney Local Health District - Royal North Shore Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
1. Adults aged 18 years and older who have sustained an acute traumatic spinal cord injury.
2. Subject has provided an informed consent.
1. Subjects with a non-traumatic spinal cord injury (eg tumours, degenerative diseases of the spinal column, vascular and autoimmune disorders)
2. Subject is currently involved in another investigational device or drug study, or <30 days since ending another investigational device of drug study or receiving an investigational agent.
3. Malignancy within the past 5 years, except for non-melanoma skin cancers, cervical or breast ductal carcinoma in situ.
4. Subjects with a known sensitivity to any of the drugs to be administered (zoledronic acid, vitamin D if required).
5. Subject is known to have any condition or illness (acute, chronic or history) which, in the opinion of the investigator, might interfere with the evaluation of the study treatment or may otherwise compromise the safety of the patient
6. Subject has any kind of disorder that, in the opinion of the investigator, may compromise the ability of the subject to give informed consent and/or to comply with all the required study procedures
7. Female subjects who, at the time of injury, are pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method